Raanana, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated ...
Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "How to Interview During GMP (Good Manufacturing Practice) Audits Training Course (Mar 12, 2026)" training has been added to ResearchAndMarkets.com's ...
Polyrizon Ltd., a biotech company developing innovative intranasal hydrogels, is preparing for a clinical trial of its PL-14 allergy blocker set for 2025. The company has partnered with Eurofins CDMO ...
BELTSVILLE, Md., March 3, 2026 /PRNewswire/ -- REPROCELL (TYO: 4978) today announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Bank (MCB) manufacturing service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results